Introduction 1
Next-generation sequencing, which allows genome-wide detection of rare and de 2 novo mutations (DNMs), is transforming the pace of genetics of human disease by 3 identifying protein-coding mutations that confer risk 1 . Various computational 4 methods have been developed to predict the effects of amino acid substitutions on 1 8
Our previously published TADA program 29 , which predicts risk genes accurately 1 on the basis of allele frequencies, gene-specific penetrance, and mutation rate, was 2 used to calculate the P value for the likelihood of each gene contributing to the all 3 four disorders with default parameters. 4 ROC curves and specificity/sensitivity estimation 5 We screened a positive (non-neutral) test set of likely casual mutations in 6 Mendelian disease from the ClinVar database (v20170130). From a total of 7 237,308 mutations in ClinVar database, we picked up 145 exonic mutations 8 presented in our curated DNMs in probands. Our negative (neutral) set of likely 9 non-casual variants was built from DNMs of unaffected controls in four 1 0 neuropsychiatric disorders. To exclude rare deleterious DNMs, we selected only 1 1 DNMs in controls with a minor allele frequency of at least 0.01 in 1000 genome 1 2 (1000g2014oct), and obtained a set of 921 exonic variants. Then, we employed R 1 3 package pROC to analyze and compare ROC curves.
1 4 Permutation analysis for overlaps of genes with piDNMs 1 5 In order to evaluate the overlap of genes among any two set of genes with piDNMs, 1 6 we shuffled the intersections of genes and repeated this procedure 100,000 times. During each permutation, we randomly selected the same number of genes as the 1 8 actual situation from the all RefSeq genes for each disorder taking account of gene-1 9 level de novo mutation rate, then P values were calculated as the proportion of 2 0 permutations during which the simulated number of overlap was greater than or 2 1 equal to the actual observed number. A gene harboring piDNMs was selected into our candidate gene set to conduct 2 4 functional enrichment analysis if it occurred in at least two of the four disorders. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) 1 pathway enrichments analyses were implemented by Cytoscape (version 3.4.0) 2 plugin ClueGO (version 2.3.0) using genome-wide coding genes as background 3 and P values calculated by hypergeometric test were corrected to be q values by 4 Benjamini-Hochberg procedure for reducing the false discovery rate resulted from 5 multiple hypothesis testing. was presented across all brain regions.
1 5
Protein-protein interaction network of cross-disorder genes 1 6
Protein-protein interactions data of Homo sapiens was collected from the STRING 1 7 (v10.5) database with score over 0.8. For the PPI network of all cross-disorder 1 8 genes, we only retain the proteins with at least two links. Those nodes with degree 1 9 over 30 in the network were considered as hubs. Cytoscape (version3.4.0) was 2 0 used to analyze and visualize protein-protein interaction networks.
1
Overrepresentation of mouse-mutant phenotypes was evaluated by the web tool 2 2
MamPhea for the genes in the PPI network and for all cross-disorder genes 2 3 containing piDNMs. The rest of genome was used as background and multiple test 2 4 adjustment for P values was done by Benjamini-Hochberg method. The available data resources 5 To make our findings easily accessible to the research community, we have 6 developed RBP-Var2 platform (http://www.rbp-var.biols.ac.cn/) for storage and 7 retrieval of piDNMs, candidate genes, and for exploring the genetic etiology of 8 neuropsychiatric disorders in post-transcriptional regulation. The expression and 9 epigenetic profiles of genes related to regulatory de novo mutations and early Leisheng Shi for his help in data analysis.
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8
The Y-axis corresponds to the -log 10 (P value) calculated by TADA. The X-axis 1 9
stands for the TADA output of -log 10 (mutation rate). (B) Scatter plot of 21 2 0 recurrent genes with p < 0.01 by TADA. The Y-axis corresponds to the -log 10 (P 2 1 value) calculated by TADA. The X-axis stands for the TADA output of - the randomness of the overlap between the 86 cross-disorder genes. We shuffled 2 5
the genes of each disorder and calculated the shared genes between the four 2 6 2 3 disorders, and repeated this procedure for 100,000 times to get the null distribution.
1
The vertical dash line indicates the observed value. piDNMs that not contained LoF mutations were also displayed. Permutation for the overlap of genes from each disorder with control. We shuffled 1 5
the genes of each disorder and calculated the shared genes between each pair, and 1 6 repeated this procedure for 100,000 times to get the null distribution. The vertical cross-disorder genes. genes during the early fetal development stages. ( 1 ) GNAS  HNRNPU  OXA1L  CTSL  ATP2B4  DEAF1  GNPTG  BAIAP2  CDC34  LLGL2  SHKBP1  AP3D1  INTS10  JARID2  MTOR  DDX50  ALS2CL  NEDD9  CIC  LLGL1  PHF19  NOTCH1  A2M  CHD5  CELSR2  OBSCN  DYNC1H1  TCF4  TNRC18  INTS1  NUMA1  COL4A3BP  MYO5A  SETD5  HBS1L  MYH10  NEB  TANC2  STXBP1  MKI67  TNPO2  KPNA1  RUSC1  DSG2  USP38  PHIP  DOT1L  MECP2  TNKS2  POGZ  RALGAPB  MDM1  PRDM4  ARMC9  MED13L  KIF18A  SPATA5  GNAO1  ALDH5A1  KIF24  ITPR1  RYR2  ZC3H3  RANBP17  PPP6R2  FHOD1  PITX1  EEF1A2  SMAP2  BCORL1  CTTNBP2  GRAMD2 
